State Board of Administration of Florida Retirement System’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,127
Closed -$203K 2173
2025
Q1
$203K Buy
+9,127
New +$188K ﹤0.01% 1877
2024
Q4
Sell
-9,127
Closed -$228K 2218
2024
Q3
$228K Buy
+9,127
New +$222K ﹤0.01% 1930
2024
Q2
Sell
-13,467
Closed -$145K 2290
2024
Q1
$145K Buy
+13,467
New +$263K ﹤0.01% 2005
2023
Q2
Sell
-13,467
Closed -$145K 2462
2023
Q1
$145K Hold
13,467
﹤0.01% 2088
2022
Q4
$202K Sell
13,467
-1,630
-11% -$23.7K ﹤0.01% 2044
2022
Q3
$194K Hold
15,097
﹤0.01% 2075
2022
Q2
$146K Buy
15,097
+10
+0.1% +$93 ﹤0.01% 2187
2022
Q1
$150K Hold
15,087
﹤0.01% 2214
2021
Q4
$178K Buy
15,087
+709
+5% +$8.71K ﹤0.01% 2240
2021
Q3
$164K Hold
14,378
﹤0.01% 2299
2021
Q2
$200K Buy
+14,378
New +$218K ﹤0.01% 2285

Other funds holding KNSA

State Board of Administration of Florida Retirement System's KNSA Position: Q2 2025 in Review

State Board of Administration of Florida Retirement System sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2025, closing a stake of 9,127 shares — an estimated $203K sold.

State Board of Administration of Florida Retirement System first reported a position in KNSA in Q2 2021 and held it in 11 quarters. The position peaked at $228K in Q3 2024. 189 funds tracked by Wall St. Rank hold KNSA as of Q2 2025.

  • State Board of Administration of Florida Retirement System reported no remaining Kiniksa Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 9,127 Kiniksa Pharmaceuticals shares in Q2 2025, an estimated $203K.
  • State Board of Administration of Florida Retirement System first reported a position in Kiniksa Pharmaceuticals in Q2 2021 and held it in 11 quarters.
  • State Board of Administration of Florida Retirement System's Kiniksa Pharmaceuticals position peaked at $228K in Q3 2024.
  • 189 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2025.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2025, filed 13 Aug 2025.